Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2025 Earnings Call Transcript August 12, 2025
Acumen Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $-0.54.
Operator: Good day, and welcome to the Acumen Pharmaceuticals Second Quarter 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Alex Braun, Head of Investor Relations. Please go ahead.
Alex Braun:...
